Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
iAPPS Health Group is a Singapore-based private Fin-MedTech company that combines financial technology, digital health, and medical services on a unified platform. The company markets a 3P Medicine model—personalised, predictive, and preventive care—delivered through products including the 1doc platform, virtual health card, e-wallet, capsule clinic, robot pharmacy, telehealth, remote patient monitoring, and wellness programs. Its business appears focused on healthcare access, provider enablement, corporate wellness, and chronic disease prevention rather than development of therapeutic drugs. The company also operates through ecosystem offerings such as HeartVoice and partners with health and technology organizations to deploy connected-care solutions. Overall, iAPPS Health Group is best characterized as a commercial digital health and healthcare services platform company, not a traditional biotech or pharma developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on iAPPS.